Market Tracker

11/27 6:05pm ET

Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

194.72
Data as of Nov 26
 +1.95 / +1.01%
Today’s Change
120.14
Today|||52-Week Range
197.64
+46.53%
Year-to-Date

Today’s Trading

Previous close192.77
Today’s open193.28
Day’s range191.52 - 194.99
Volume704,468
Average volume (3 months)1,123,763
Market cap$38.6B
Dividend yield--
Data as of 4:00pm ET, 11/26/2014

Growth & Valuation

Earnings growth (last year)-0.78%
Earnings growth (this year)+68.86%
Earnings growth (next 5 years)+25.35%
Revenue growth (last year)+34.85%
P/E ratio81.1
Price/Sales17.19
Price/Book16.10

Competitors

 Today’s
change
Today’s
% change
SHPGShire+2.44+1.15%
VRXValeant Pharmaceutic...-0.03-0.02%
VRTXVertex Pharmaceutica...+1.20+1.05%
ZTSZoetis Inc+0.76+1.73%
Data as of 4:02pm ET, 11/26/2014

Financials

Next reporting dateFebruary 12, 2015
EPS forecast (this quarter)$1.29
Annual revenue (last year)$1.5B
Annual profit (last year)$252.9M
Net profit margin16.73%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, CEO, Treasurer &
Director
Leonard Bell
Chief Operating Officer &
Director
David L. Hallal
Corporate headquarters
Cheshire, Connecticut

Forecasts